2 ne ne TE Sp 2 tr “| Summary of Thyroid Reaults & You ah, = Py Table 25 Age at Exposure Rongelap In Utero <10 10-18 >18 All Ages Total Number 3 15 3 3 23 l 0 It 4 Sifo <10 10-18 - All Agee 19 Utirik In Utero <10 . 10-18 >18 All Agee All Exposed In Utero <10 10-18 >18 All Ages 8 No. with Carcinoma 2 ige 12 3 65 “InUterc 218 Nodules® 0 \ ] 2 4 0 0.079 0.50 0.92 2.7 4.2 0.026 Expected Cancers>s¢ 0.026 0.17 0.15 0.21 0.56 0.0087 640 4000 1700 1300 2100 610 Mean Nodule Time at Risk (Cancer), years 23(-) 13(15) 17(22) 17(13) 15(16) -(-) Mean Nodule Risk, No. per 10 person-radyeara 43 15 6.0 0.44 9.2 2 - 0 - 0.18 - 0.061 - 1100 - 22¢-). -(-) il 6 0 1.2 0.15 670 19{-) 20 0 0 0 167 17 12 82 31 126 251 2 21 7 16 46 56 19 64 Expected Nodules>s© Mean Adsorbed Dose, rads 4 4 9 i 2 1 0.98 0.21 0.075 0.070 410 130 18(-) -(-) 47 - Mean Cancer Risk, No. per 10 person-radyeare - 0.73 1.9 3.4 1.6. - - - - - - 4 1.5 1.4 7.5 11 0.49 0.24 0.58 490 220 170 25(21) 22(22) 22(22) 3.6 2? 4.8 0.89 19. 1.3 0 2 3 3 6 0.32 2.2 2.3 Il 16 0.10 0.72 0.39 0.87 2.1 290 1400 790 470 600 23(-) 16(18) 20(22) 20(16) 18(19) 21 10 9.6 4.4 8.3 0.65 3.1 2.2 1.5 ®Iincludes some cases not surgically treated. bBased on prevalence in unexposed Marshallese. “In utero values based on age less than ten prevalence. Smultiply by 100 to obtain number per 106 per son-gray-yeara. ®Does not include two boys with thyroid atrophy. 1.4 280 23(22) 5.9 (2.5